Literature DB >> 17119877

Milrinone administered before ischemia or just after reperfusion, attenuates myocardial stunning in anesthetized swine.

Tadasuke Use1, Tetsuji Makita, Hiroyuki Ureshino, Sungsam Cho, Osamu Yoshitomi, Daiji Akiyama, Motoko Oshibuchi, Tetsuya Hara, Koji Sumikawa.   

Abstract

PURPOSE: We assessed the dose or timing effect of milrinone administered against myocardial stunning in 37 anesthetized open-chest swine.
METHODS: All swine were subjected to 12-min ischemia followed by reperfusion to produce myocardial stunning. Group A (n = 12) received saline in place of milrinone both before and after ischemia. Group B (n = 9) and C (n = 9) received intravenous milrinone at a rate of 5 microg/kg/min for 10 min followed by 0.5 microg/kg/min for 10 min and 10 microg/kg/min for 10 min followed by 1 microg/kg/min for 10 min, respectively, until 30 min before coronary occlusion. Group D (n = 7) received the same dose of milrinone as group B starting 1 min after reperfusion. Myocardial contractility was assessed by percentage segment shortening (%SS).
RESULTS: Five swine in group A and two swine in groups B and C each had ventricular fibrillation or tachycardia after reperfusion, and were thus excluded from further analysis. The percentage changes of %SS from the baseline 90 min after reperfusion in groups B, C, and D were 78 +/- 9%, 82 +/- 13%, and 79 +/- 7%, respectively, which were significantly higher than those in group A (43 +/- 13%).
CONCLUSION: We conclude that milrinone administered before ischemia or just after reperfusion attenuates myocardial stunning.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17119877     DOI: 10.1007/s10557-006-0166-7

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  2 in total

1.  Postischemic infusion of sivelestat sodium hydrate, a selective neutrophil elastase inhibitor, protects against myocardial stunning in swine.

Authors:  Daiji Akiyama; Tetsuya Hara; Osamu Yoshitomi; Takuji Maekawa; Sungsam Cho; Koji Sumikawa
Journal:  J Anesth       Date:  2010-05-13       Impact factor: 2.078

Review 2.  Pivotal effects of phosphodiesterase inhibitors on myocyte contractility and viability in normal and ischemic hearts.

Authors:  Yuan James Rao; Lei Xi
Journal:  Acta Pharmacol Sin       Date:  2008-12-08       Impact factor: 6.150

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.